内脏动脉瘤腔内治疗研究进展  

Research progress of endovascular treatment in visceral artery aneurysms

作　　者：葛炳豪(综述) 仲崇俊[1] 明志兵(审校)[1] GE Binghao;ZHONG Chongjun;MING Zhibing(Department of Thoracic and Cardiovascular Surgery,the Second Affiliated Hospital of Nantong University,Nantong 226001)

机构地区：[1]南通大学第二附属医院胸心血管外科,南通226001

出　　处：《南通大学学报（医学版）》2020年第3期260-263,共4页Journal of Nantong University(Medical sciences)

基　　金：南通市科技项目(MS12018056);南通市医学重点人才项目(重点12);江苏省“六大人才高峰”高层次人才项目(WSN-269)。

摘　　要：内脏动脉瘤(visceral artery aneurysms,VAAs)是指腹主动脉所从属的各条内脏动脉及其分支产生的动脉瘤,在临床上较为少见,其主要病因包括动脉粥样硬化、肌纤维发育不良、动脉管壁中膜变性、外伤、医源性损伤、先天性异常、感染、结节性动脉炎、门静脉高压等。内脏动脉瘤以往治疗手段主要是外科手术,随着介入放射学不断发展,血管腔内治疗VAAs已成为临床首选,且取得了满意的临床疗效。本文旨在综述目前内脏动脉瘤腔内治疗的方法、疗效及安全性。Visceral artery aneurysm(VAAs)refer to the aneurysms produced by the visceral arteries which belong to the abdominal aorta and their branches.It is rare in clinical practice,and its causes mainly include atherosclerosis,fibromuscular dysplasia,media layer degeneration of arterial wall,trauma,iatrogenic injury,congenital anomalies,infection,nodular arteritis,portal hypertension,etc.The main treatment of visceral artery aneurysm is surgery in the past,with the continuous development of interventional radiology,endovascular treatment of VAAs has become the first choice in clinical practice and has achieved satisfactory clinical results.This article aims to review the current treatment,efficacy and safety of interventional treatment of VAAs.

关 键 词：内脏动脉瘤 腔内治疗 覆膜支架 栓塞治疗 

分 类 号：R543[医药卫生—心血管疾病]